The cherished “Pap”

Loutradis Dimitris

It was in 1943 when Dr George Papanicolaou opened new horizons in the field of cervical cancer prevention, by communicating his research on vaginal cytology as an indicator of cervical cancer. Thereafter, the accessibility of the Pap test to the female population dramatically reduced the cervical cancer incidence and was thus established as the most efficient screening test ever …


Mobile Hysteroscopy

Ioannis Chatzipapas, Nikolaos Kathopoulis, Athanasios Protopapas, Dimitrios-Euthimios Vlachos, Dimitrios Loutradis

Introduction: The purpose of this study was to evaluate the feasibility and clinical outcome of a new setup for diagnostic hysteroscopy using mobile technology. Materials and Methods: A total of 15 women with indications of diagnostic hysteroscopy were examined according to the new setup using smartphone and portable …


HPV DNA testing versus Cytology: A new era in cervical cancer screening

Antonis Sfakianakis, Kalliopi Pappa

Cervical cancer screening tests are growing at a rapid pace, reflecting the importance of the HPV virus in the development of cancer. Four randomized studies in Europe and one perspective study in the USA have substantiated the application of HPV DNA screening (HPV testing), as a triage trial for cervical cancer …


Pregnancy associated cancer: General principles

Ioannis Rellias, Alexandra Tsigginou, Flora Zagouri, Spyridon Marinopoulos, Aris Giannos, Kalliopi Pappa, Constantine Dimitrakakis

Pregnancy associated cancer is defined as the cancer diagnosed during pregnancy or within 1 year postpartum. Since women seem to be delaying childbearing to later ages than in previous generations, the incidence of cancer during pregnancy is constantly increasing. Treatment of cancer during pregnancy is a difficult clinical …